Adipose tissue function in the insulin-resistance syndrome

被引:30
|
作者
Karpe, F [1 ]
Tan, GD [1 ]
机构
[1] Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England
关键词
adipose tissue; fatty acid; insulin resistance; non esterified fatty acid (NEFA); thiazolidinedione; Type II diabetes;
D O I
10.1042/BST0331045
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Insulin resistance is often seen as a consequence of obesity and there are several possible links between adipose tissue function and insulin resistance determined in other organs such as skeletal muscle or liver. one such link is the regulation of NEFA (non-esterified fatty acid) delivery to the rest of the body. Simplistically, an expanded adipose tissue mass delivers more NEFA to the systemic circulation and these fatty acids compete for substrate utilization in skeletal muscle, which in turn reduces glucose utilization. This increases blood glucose concentration and provides the stimulus for increased insulin secretion and hyperinsulinaemia is a key feature of the insulin-resistance syndrome. However, there is abundant evidence that adipose tissue is exquisitely insulin sensitive and hypeirinsulinaemia may therefore lead to a constant lipolytic inhibition in adipose tissue. Consequently, the main function of adipose tissue, to rapidly switch between fat uptake and fat release, will be hampered. Adipose tissue blood flow is the conveyor of signals and substrates to and from the adipose tissue. in healthy people adipose tissue blood flow is much enhanced by food intake, whereas in insulin-resistant subjects this response is blunted. This is another facet of unresponsiveness of adipose tissue in the insulin-resistance syndrome.
引用
收藏
页码:1045 / 1048
页数:4
相关论文
共 50 条
  • [1] Adipose tissue and the insulin resistance syndrome
    Frayn, KN
    [J]. PROCEEDINGS OF THE NUTRITION SOCIETY, 2001, 60 (03) : 375 - 380
  • [2] INSULIN-RESISTANCE - SYNDROME OR TENDENCY
    GODSLAND, IF
    STEVENSON, JC
    [J]. LANCET, 1995, 346 (8967): : 100 - 103
  • [3] SHORT SYNDROME AND INSULIN-RESISTANCE
    SCHWINGSHANDL, J
    MACHE, CJ
    RATH, K
    BORKENSTEIN, MH
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS, 1993, 47 (06): : 907 - 909
  • [4] HYPOFIBRINOLYSIS AND THE INSULIN-RESISTANCE SYNDROME
    VAGUE, P
    RACCAH, D
    SCELLES, V
    [J]. INTERNATIONAL JOURNAL OF OBESITY, 1995, 19 : S11 - S15
  • [5] Relationship of circulating levels and adipose tissue expression of adiponectin with insulin-resistance in severe obesity
    Camastra, Stefania
    Muscelli, Elza
    Gastaldelli, Amalia
    Baldi, Simona
    Nannipieri, Monica
    Scartabelli, Giovanna
    Anselmino, Marco
    Bonotti, Alessandra
    Santini, Ferruccio
    Ferrannini, Eleuterio
    [J]. INTERNATIONAL JOURNAL OF OBESITY, 2007, 31 : S64 - S64
  • [6] Severe Insulin Resistance with Pseudoacromegaly, a Rare Insulin-Resistance Syndrome
    Stone, Stephen I.
    Wambach, Jennifer A.
    Cole, F. S.
    Wegner, Daniel J.
    Urano, Fumihiko
    [J]. DIABETES, 2017, 66 : A6 - A6
  • [7] NUTRITIONAL DETERMINANTS OF THE INSULIN-RESISTANCE SYNDROME
    TREMBLAY, A
    [J]. INTERNATIONAL JOURNAL OF OBESITY, 1995, 19 : S60 - S68
  • [8] Micropolycystic ovaries and insulin-resistance syndrome
    Lorcy, Y
    [J]. ANNALES D ENDOCRINOLOGIE, 2005, 66 (01) : 18 - 23
  • [9] INSULIN-RESISTANCE IN SYNDROME-X
    CHAUHAN, A
    PETCH, MC
    SCHOFIELD, PM
    [J]. LANCET, 1993, 342 (8870): : 554 - 554
  • [10] Adipokine genes and the insulin-resistance syndrome
    Doria, A
    [J]. METABOLIC SYNDROME: DIABETES, OBESITY, HYPERLIPIDEMIA AND HYPERTENSION, 2003, 1253 : 63 - 71